Scientists at the RCSI University of Medicine and Health Sciences in Dublin, Ireland, have discovered a new role for the blood clotting protein, von Willebrand Factor (VWF), that could lead to the ...

Biomedical engineers report a new application for their synthetic platelets: treating the genetic condition that prevents blood from clotting, Von Willebrand disease (VWD). The most common of all ...

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

Scientists have identified the specific structural element of von Willebrand Factor that allows it to bind with platelets and initiate blood clotting. The team says that the specific unit, which they ...